Enzymatica AB: Continued lower sales due to pandemic but some stabilization

STOCKHOLM, July 16, 2021 /PRNewswire/ -- Q2 Net sales reached SEK 6.1 (13.9) million. Result after tax came in at SEK -19.7 (-11.7) million. Earnings per share, basic and diluted, were SEK -0.14 (-0.08). Cash and cash equivalents were SEK 64.8 (30.9) million. Significant events in Q1...

from PR Newswire: https://ift.tt/3idYxEx